DavidJonGordonMDPhD

Pediatric Hematology & Oncology • Iowa City, IA

Associate Professor, Pediatrics, Division of Hematology/Oncology, University of Iowa Children's Hospital

Join to view full profile

Dr. Gordon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gordon's full profile

Already have an account?

Office
200 Hawkins Dr
Iowa City, IA 52242
Phone+1 319-384-5108

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
Children's Hospital of PhiladelphiaResidency, Pediatrics, 2004 - 2007
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2004

Certifications & Licensure

IA State Medical License 2014 - 2026
MA State Medical License 2010 - 2015
PA State Medical License 2006 - 2008
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

EWS-FLI1 and Activator Protein-1 (AP-1) Reciprocally Regulate Extracellular-Matrix Proteins in Ewing sarcoma Cells.
Emma E Croushore, Christopher S Stipp, David J Gordon
International Journal of Molecular Sciences. 2024-08-06
Auranofin and reactive oxygen species inhibit protein synthesis and regulate the level of the PLK1 protein in Ewing sarcoma cells.
Joseph A Haight, Stacia L Koppenhafer, Elizabeth L Geary, David J Gordon
Frontiers in Oncology. 2024-01-01
4 citations
Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress.
Emma E Croushore, Stacia L Koppenhafer, Kelli L Goss, Elizabeth L Geary, David J Gordon
Cancer Research Communications. 2023-08-01